Answers are grounded in this paper and cite their sources.
Retrospective study demonstrates the utility of multimodal MRI features in differentiating pure from mixed mucinous breast carcinoma, highlighting MRI's value when biopsy sampling is limited.
Objective: This study aimed to evaluate the efficacy of mammography, ultrasound, and magnetic resonance imaging (MRI) features in differentiating pure from mixed mucinous breast carcinoma and in identifying imaging characteristics specific to each subtype. Methods: This retrospective single-center study included 68 patients diagnosed with mucinous breast carcinoma between 2017 and 2024. The tumors were classified as pure or mixed mucinous breast carcinomas based on histopathological findings. All available mammography, ultrasound, and MRI examinations were evaluated by a radiologist blinded to the histopathological subtypes. The features, such as tumor shape, margin, signal intensity, mammographic density, echogenicity, and calcifications, were assessed to identify distinctive patterns associated with pure and mixed mucinous breast tumors. Results: mm²/s, p=0.01). Conclusions: A multimodal imaging approach facilitates differentiation between pure and mixed mucinous breast carcinomas. Among the evaluated modalities, MRI provided the greatest discriminatory value, particularly through T2 signal intensity and ADC measurements, and may complement core needle biopsy when tissue sampling is limited.
No takes yet. Share an insight, caveat, or question.
Erdem et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: